Skip to content
hexamethonium

Structure via PubChem · Public domain (PubChem)

EntityQ410557· pop 11· linked from 434 articles

hexamethonium

Sign in to save

Also known as N,N,N,N',N',N'-hexamethylhexane-1,6-diaminium

Hexamethonium is a non-depolarising ganglionic blocker, a neuronal nicotinic (nAChR) receptor antagonist that acts in autonomic ganglia by binding mostly in or on the nAChR receptor, and not the acetylcholine binding site itself. It does not have any effect on the muscarinic acetylcholine receptors (mAChR) located on target organs of the parasympathetic nervous system, nor on the nicotinic receptors at the skeletal neuromuscular junction, but acts as antagonist at the nicotinic acetylcholine receptors located in sympathetic and parasympathetic ganglia (nAChR).

Chemical data

Formula
C12H30N2+2
Molecular weight
202.38 g/mol
IUPAC name
trimethyl-[6-(trimethylazaniumyl)hexyl]azanium

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule

via ChEMBL · EBI

Research

7,440 papers

via PubMed

Wikidata facts

Mass
202.23980180017998
Show 4 more facts
canonical SMILES
C[N+](C)(C)CCCCCC[N+](C)(C)C
subject has role
nicotinic antagonist
Commons category
Hexamethonium
chemical formula
C₁₂H₃₀N₂²⁺
Sources (3)

via Wikidata · CC0

~2 min read

Encyclopedic overview

4 sections
Contents
  • Pharmacology
  • Uses
  • See also
  • References

Hexamethonium is a non-depolarising ganglionic blocker, a neuronal nicotinic (nAChR) receptor antagonist that acts in autonomic ganglia by binding mostly in or on the nAChR receptor, and not the acetylcholine binding site itself. It does not have any effect on the muscarinic acetylcholine receptors (mAChR) located on target organs of the parasympathetic nervous system, nor on the nicotinic receptors at the skeletal neuromuscular junction, but acts as antagonist at the nicotinic acetylcholine receptors located in sympathetic and parasympathetic ganglia (nAChR).

== Pharmacology ==

Excerpted from Wikipedia’s “hexamethonium” article, available under the CC BY-SA 4.0 licence.